ICLUSIG^® (ponatinib) is now available in 10-mg and 30-mg tablet strengths. Please see table below for National Drug Code (NDC) numbers and descriptions for all ICLUSIG presentations.

ICLUSIG NDC numbers and tablet strengths

In addition, the US Food and Drug Administration (FDA) has approved a label update for ICLUSIG. The updated Prescribing Information contains the new indication, dosing information, and updated safety information.

Please click the link for ICLUSIG full Prescribing Information, including Boxed Warning.

To learn more about ICLUSIG, please visit www.iclusig.com/hcp.

I look forward to meeting with you soon to provide more information about ICLUSIG and to answer any questions you may have.